Results 181 to 190 of about 112,553 (254)

Near-Infrared Luminescence from Transparent Thin Films of Copper(I) Thiocyanate Modified with 2-Mercaptobenzothiazole via Excited-State Symmetry Breaking. [PDF]

Inorg Chem
Waiprasoet S, Hume PA, Scott JM, Nalaoh P, Prayongkul P, Packwood DM, Hodgkiss JM, Harding DJ, Pattanasattayavong P.   +8 more
europepmc   +1 more source

Exploring Salivary Thiocyanate as a Novel Biomarker of Physical Activity Response. [PDF]

Molecules
Chrimatopoulos C, Papadopoulou K, Tsilouli T, Sakkas V.   +3 more
europepmc   +1 more source

Schmidt Reaction of Hydroxyalkyl Azides with Acyclic Ketones. [PDF]

J Org Chem
Zhang X, Sherrier RP, Aubé J.
europepmc   +1 more source

Exposure to perchlorate, nitrate and thiocyanate was associated with the prevalence of hypertension. [PDF]

BMC Cardiovasc Disord
Miao X, Chen Y, Lu J, Shan H, Chen R.
europepmc   +1 more source

On the molecular mechanisms of konzo and neurolathyrism [PDF]

, 2011
Diasolua Ngudi, Delphin, Kuo, Yu-Haey, Lambein, Fernand, Van Moorhem, Marijke   +3 more
core   +1 more source

Aqueous Biphasic Systems Based on Tetrabutylammonium Bromide for Extraction and Determination of Azorubine, Allura Red, Sunset Yellow, Tartrazine and Fast Green in Food Samples. [PDF]

Molecules
Smirnova SV, Gorbovskaia AV, Vershinina YS, Apyari VV, Proskurnin MA.   +4 more
europepmc   +1 more source

Dicyclohexylammonium thiocyanate

Dicyclohexylammonium thiocyanate
application/pdf 論文(Article)
openaire  

Can Semilocal Approximations to the Embedding Potential Tackle Charge-Transfer-to-Solvent Excitations? An Aqueous Thiocyanate Example. [PDF]

J Chem Theory Comput
Roy PO, Fu M, Sarangi R, Krylov AI, Wesolowski TA.   +4 more
europepmc   +1 more source

Liquid-Liquid Interface-Based Thiocyanate Surface Treatment for Bright and Stable CsPbBr₃ Nanocrystals. [PDF]

Chem Mater
Lifer R, Rafisiman N, Shaek S, Basu A, Kauffmann Y, Pavlopoulos NG, Castelli IE, Chuntonov L, Bekenstein Y.   +8 more
europepmc   +1 more source

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements. [PDF]

J Clin Invest
DiNapoli SR, Wright KM, Mog BJ, Pearlman AH, Nichakawade TD, Marcou N, Hsiue EH, Hwang MS, Douglass J, Liu Q, Watson E, Dal Molin M, Cohen JD, Popoli M, Paul S, Konig MF, Wyhs N, Azurmendi PA, Glavaris S, Ge J, Awosika TO, Liu J, Gabrielson KL, Gabelli SB, Pardoll DM, Bettegowda C, Papadopoulos N, Kinzler KW, Zhou S, Vogelstein B.   +29 more
europepmc   +1 more source